CYPH — Cypherpunk Technologies Share News
0.000.00%
Last trade - 00:00- $321.14m
- $313.51m
Leap Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Leap Therapeutics Reports First Quarter 2023 Financial Results
Brief: Leap Therapeutics Inc Reports QTRLY Loss Per Share $0.32
Leap Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Leap Therapeutics Inc Files For Potential Offering Of 147.1 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
U.S. STOCKS ON THE MOVE-SiriusPoint, Nutex Health, Barrick Gold
U.S. STOCKS ON THE MOVE-SiriusPoint, Shopify, Gold miners
U.S. STOCKS ON THE MOVE-Triton, TESSCO, Creative Medical
Leap Therapeutics rise on colorectal cancer study enrollment milestone
Brief: Leap Therapeutics Announces Completion Of Enrollment In Part A Of DeFianCe Study of DKN-01 For Treatment Of Colorectal Cancer Patients
U.S. RESEARCH ROUNDUP- Marathon Petroleum, Nvidia, Repligen
Leap Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Leap Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results
Brief: Leap Therapeutics Provides Update On Beigene Option Agreement For DKN-01
Leap Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview
Tesla's China sales slow as price-cut boost wanes
U.S. RESEARCH ROUNDUP-Adobe, GoDaddy, Shopify
Leap Therapeutics falls on acquiring private biotech Flame Biosciences
Leap Therapeutics falls on acquiring private biotech Flame Biosciences